In recent months China’s progress in artificial intelligence has stunned the world. A quieter yet equally significant shift ...
China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the ...
China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals, saying an investigation into quality ...
Hosted on MSN14d
Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicineThe most common intervention type was fixed CHM formulas, followed by individualized prescriptions and Chinese patent medicines. The reporting quality of the RCTs was suboptimal, with an average ...
Because of expiring drug patents, they stand to lose as much ... In November Merck paid $588m to LaNova Medicines, another Chinese biotech firm, to secure rights to a therapy similar to that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results